UPDATE: Puma Biotech (PBYI) Sees Heavy Selling Pressure; SABCS Abstracts Released

November 14, 2016 10:40 AM EST

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
(Updated - November 14, 2016 10:55 AM EST)

Puma Biotech (NYSE: PBYI) is under heavy pressure. Shares down 17.7%

UPDATE: Downdside could be coming as SABCS abstracts were released. Link

There is also talk amongst traders about a PR Friday discussing a shareholder investigation. Shares last traded down 35% before being halted on a circuit breaker.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

FDA, Trader Talk

Add Your Comment